Johnson & Johnson and Viz.ai are pairing J&J’s neurovascular portfolio with Viz.ai’s FDA 510(k)-cleared Subdural Hemorrhage ...
Medtronic (NYSE:MDT) announced today that it launched its adaptive deep brain stimulation (aDBS) system in India.
Lucid Diagnostics (Nasdaq:LUCD) announced today that it closed a registered direct offering worth proceeds of $18 million.
AngioDynamics has filed a lawsuit against Endovascular Engineering (E2) in the U.S. District Court for the District of ...
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its ApexCut surgical blades for ENT procedures.
Johnson & Johnson (NYSE:JNJ) announced today that it entered into a definitive agreement to acquire Atraverse Medical.
Johnson & Johnson (NYSE:JNJ) today announced the initiation of a new trial evaluating competitive pulsed field ablation (PFA) ...